1. Home
  2. HY vs SLDB Comparison

HY vs SLDB Comparison

Compare HY & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hyster-Yale Materials Handling Inc.

HY

Hyster-Yale Materials Handling Inc.

N/A

Current Price

$35.33

Market Cap

640.3M

Sector

Industrials

ML Signal

N/A

Logo Solid Biosciences Inc.

SLDB

Solid Biosciences Inc.

N/A

Current Price

$6.54

Market Cap

674.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HY
SLDB
Founded
1991
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
640.3M
674.4M
IPO Year
2012
2017

Fundamental Metrics

Financial Performance
Metric
HY
SLDB
Price
$35.33
$6.54
Analyst Decision
Strong Buy
Analyst Count
0
11
Target Price
N/A
$16.36
AVG Volume (30 Days)
71.7K
1.1M
Earning Date
05-05-2026
05-12-2026
Dividend Yield
3.76%
N/A
EPS Growth
N/A
34.97
EPS
N/A
N/A
Revenue
$3,769,300,000.00
$8,094,000.00
Revenue This Year
$1.37
N/A
Revenue Next Year
$5.29
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$26.41
$3.79
52 Week High
$44.55
$8.87

Technical Indicators

Market Signals
Indicator
HY
SLDB
Relative Strength Index (RSI) 48.46 43.47
Support Level $35.16 $6.20
Resistance Level $38.48 $6.87
Average True Range (ATR) 1.62 0.42
MACD 0.07 0.00
Stochastic Oscillator 74.33 34.00

Price Performance

Historical Comparison
HY
SLDB

About HY Hyster-Yale Materials Handling Inc.

Hyster Yale Inc designs, engineers, manufactures, sells, and services a comprehensive line of lift trucks, attachments, aftermarket parts, and technology solutions marketed globally under the Hyster and Yale brand names. The company has four segments, which include three in the lift truck business as discussed below, as well as Bolzoni S.p.A. (Bolzoni). The majority of its revenue is generated from Lift Trucks. Geographically, it operates in America, EMEA, and JAPIC regions, of which maximum revenue is generated from its business in America, which includes lift truck operations in the U.S., Canada, Mexico, Brazil, and Latin America.

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life sciences company focused on advancing a portfolio of current and future gene therapy candidates, including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-212 for the treatment of Friedreich's ataxia, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, SGT-601 for the treatment of TNNT2-mediated dilated cardiomyopathy, and additional assets for the treatment of genetic cardiac and neuromuscular diseases. The majority of its current programs are designed to treat these diseases with gene transfer products. The company operates in a single segment, developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases.

Share on Social Networks: